Full Text (PDF)
Short Communication

Prevention of Malaria

Arvind Nath

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Preventive Medicine 10(1):p 23-25, January-June 2022. | DOI: https://doi.org/10.21088/ijpm.2321.5917.10122.3

How Cite This Article:

Arvind Nath/Prevention of Malaria/Indian J Prev Med. 2022;10(1):23-25.

Timeline

Received : February 16, 2022         Accepted : March 16, 2022          Published : June 30, 2022

Abstract

NA


References

  • 1.   American Public Health Association. Malaria. In Control of Communicable Diseases Manual 20th Edition, Washington D.C., U.S.A. 2016. Information as of 26 August 2021. Available at https://ccdm.aphapublications.org/doi/epdf/10.2105/CCDM.2745.097 Accessed on 11 February 2022.
  • 2.   World Health Organization. International Travel and Health. Situation as of 1 January 2012. Updates 2019. Geneva. Available athttps://www.who.int/publications/i/item/9789241580472 Accessed on 14 February 2022.
  • 3.   World Health Organization. 2021 News. Geneva. Available at https://www.who.int/ news/item/06-10-2021-who-recommendsgroundbreaking-malaria-vaccine-for-childrenat-risk/Accessed on 13 October 2021.
  • 4.   Vandoolaeghe P. and Schuerman L. 2016. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Expert Rev. Vaccines2016 Dec;15(12):1481-1493.DOI: 10.1080/14760584.2016.1236689. Available at https://pubmed.ncbi.nlm.nih.gov/27841689/Accessed on 13 October 2021.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Arvind Nath/Prevention of Malaria/Indian J Prev Med. 2022;10(1):23-25.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
February 16, 2022 March 16, 2022 June 30, 2022

DOI: https://doi.org/10.21088/ijpm.2321.5917.10122.3

Keywords


Article Level Metrics

Last Updated

Saturday 18 July 2026, 12:19:11 (IST)


768

Accesses

1
217
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received February 16, 2022
Accepted March 16, 2022
Published June 30, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share